GlassScriptPhysician profile
Samuel J Romeo
NPI 1225131295
$65,961.74
in general payments reported to CMS, 2019-2025
8 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $84.80 · 2021: $5,745 · 2022: $86.75 · 2023: $211 · 2024: $43K · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $42K · Food and Beverage: $670 · Education: $42.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $42,450.00 |
| Food and Beverage | $670.19 |
| Education | $42.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $42,463.07 | 2020-2024 | |
| Allergan, INC. | $22,660.05 | 2019-2022 | |
| Abbvie INC. | $687.67 | 2023-2025 | Botox, Kybella |
| Silk Road Medical, INC. | $42.58 | 2019 | |
| Horizon Therapeutics Plc | $36.35 | 2019 | |
| Revance Therapeutics, INC. | $24.77 | 2024 | Daxxify |
| Sanofi Pasteur INC. | $24.05 | 2019 | |
| Orthogenrx INC. | $23.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Romeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.